skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians

Review

(1790) Views  (529) Full article downloads

Authors: Yawn BP, Thomashow B

Published Date September 2011 Volume 2011:4 Pages 665 - 676
DOI: http://dx.doi.org/10.2147/IJGM.S22878

Barbara P Yawn1, Byron Thomashow2
1Department of Research, Olmsted Medical Center, Rochester, MN, USA; 2Division of Pulmonary, Allergy, Critical Care, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY, USA

Abstract: Current treatments have failed to stem the continuing rise in health care resource use and fatalities associated with exacerbations of chronic obstructive pulmonary disease (COPD). Reduction of severity and prevention of new exacerbations are therefore important in disease management, especially for patients with frequent exacerbations. Acute exacerbation treatment includes short-acting bronchodilators, systemic corticosteroids, and antibiotics if bacterial infections are present. Oxygen and/or ventilatory support may be necessary for life-threatening conditions. Rising health care costs have provided added impetus to find novel therapeutic approaches in the primary care setting to prevent and rapidly treat exacerbations before hospitalization is required. Proactive interventions may include risk reduction measures (eg, smoking cessation and vaccinations) to reduce triggers and supplemental pulmonary rehabilitation to prevent or delay exacerbation recurrence. Long-term treatment strategies should include individualized management, addressing coexisting nonpulmonary conditions, and the use of maintenance pharmacotherapies, eg, long-acting bronchodilators as monotherapy or in combination with inhaled corticosteroids to reduce exacerbations. Self-management plans that help patients recognize their symptoms and promptly access treatments have the potential to prevent exacerbations from reaching the stage that requires hospitalization.

Keywords: COPD, beta-agonists, anticholinergics, self-management plan

 






 

Other articles by Dr Barbara Yawn



Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Usefulness of inspiratory capacity measurement in COPD patients in the primary care setting
Methemoglobinemia due to topical pharyngeal anesthesia during endoscopic procedures
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
Community-acquired pneumonia due to Legionella pneumophila, the utility of PCR, and a review of the antibiotics used
Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Why are some evidence-based care recommendations in chronic obstructive pulmonary disease better implemented than others? Perspectives of medical practitioners
Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease
Factors related to suicide attempts among individuals with major depressive disorder
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University